183 related articles for article (PubMed ID: 8443002)
21. Eldecalcitol and calcitriol stimulates 'bone minimodeling,' focal bone formation without prior bone resorption, in rat trabecular bone.
Saito H; Takeda S; Amizuka N
J Steroid Biochem Mol Biol; 2013 Jul; 136():178-82. PubMed ID: 23069645
[TBL] [Abstract][Full Text] [Related]
22. 1,25-dihydroxyvitamin D3 as well as its analogue OCT lower blood calcium through inhibition of bone resorption in hypercalcemic rats with continuous parathyroid hormone-related peptide infusion.
Endo K; Katsumata K; Hirata M; Masaki T; Kubodera N; Nakamura T; Ikeda K; Ogata E
J Bone Miner Res; 2000 Jan; 15(1):175-81. PubMed ID: 10646127
[TBL] [Abstract][Full Text] [Related]
23. Effects of 1 alpha, 25-dihydroxyvitamin D3-26,23-lactone and its intermediate metabolites on bone metabolism in vivo and in vitro.
Kumegawa M; Ishizuka S; Sumitani K; Hiura K; Kawata T; Okawa M; Hakeda Y
Contrib Nephrol; 1991; 91():109-15. PubMed ID: 1666030
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of 1,25-dihydroxyvitamin D3-analogs on osteoblast-like cells and on in vitro bone resorption.
van den Bemd GJ; Pols HA; Birkenhäger JC; Kleinekoort WM; van Leeuwen JP
J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):337-46. PubMed ID: 8541230
[TBL] [Abstract][Full Text] [Related]
25. Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3.
Norman AW; Bouillon R; Farach-Carson MC; Bishop JE; Zhou LX; Nemere I; Zhao J; Muralidharan KR; Okamura WH
J Biol Chem; 1993 Sep; 268(27):20022-30. PubMed ID: 8397195
[TBL] [Abstract][Full Text] [Related]
26. Effect of 1,25-dihydroxyvitamin D3 on the proliferation of osteoblastic MC3T3-E1 cells by modulating the release of local regulators from monocytes.
Kanatani M; Sugimoto T; Fukase M; Chihara K
Biochem Biophys Res Commun; 1993 Jan; 190(2):529-35. PubMed ID: 8427595
[TBL] [Abstract][Full Text] [Related]
27. Differential time course of induction of 1alpha,25-dihydroxyvitamin D3-24-hydroxylase mRNA expression in rats by 1alpha,25-dihydroxyvitamin D3 and its analogs.
Furuichi T; Kawata S; Asoh Y; Kumaki K; Ohyama Y
Life Sci; 1998; 62(5):453-9. PubMed ID: 9449236
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway.
Lerner UH
J Bone Miner Res; 1996 Nov; 11(11):1628-39. PubMed ID: 8915770
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the 1,25-(OH)2D3-induced inhibition of bone nodule formation in long-term cultures of fetal rat calvaria cells.
Ishida H; Bellows CG; Aubin JE; Heersche JN
Endocrinology; 1993 Jan; 132(1):61-6. PubMed ID: 8419147
[TBL] [Abstract][Full Text] [Related]
30. Differential regulation of insulin-like growth factor-I (IGF-I) and IGF-II release from cultured neonatal mouse calvaria by parathyroid hormone, transforming growth factor-beta, and 1,25-dihydroxyvitamin D3.
Linkhart TA; Keffer MJ
Endocrinology; 1991 Mar; 128(3):1511-8. PubMed ID: 1999170
[TBL] [Abstract][Full Text] [Related]
31. Influence of vitamin D3 metabolites on the production of interleukins 1,2 and 3.
Hodler B; Evêquoz V; Trechsel U; Fleisch H; Stadler B
Immunobiology; 1985 Nov; 170(4):256-69. PubMed ID: 3002965
[TBL] [Abstract][Full Text] [Related]
32. A novel synthetic vitamin D analogue, 2 beta-(3-hydroxypropoxy)1 alpha, 25-dihydroxyvitamin D3 (ED-71), increases bone mass by stimulating the bone formation in normal and ovariectomized rats.
Tsurukami H; Nakamura T; Suzuki K; Sato K; Higuchi Y; Nishii Y
Calcif Tissue Int; 1994 Feb; 54(2):142-9. PubMed ID: 8012869
[TBL] [Abstract][Full Text] [Related]
33. [Current Topics on Vitamin D. The role of active forms of vitamin D in regulation of bone remodeling].
Nakamichi Y; Takahashi N
Clin Calcium; 2015 Mar; 25(3):395-402. PubMed ID: 25716813
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of all possible A-ring diastereomers at the 1- and 3-positions of 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3 (ED-71) using C2-symmetrical epoxide as a common starting material.
Kubodera N; Hatakeyama S
Anticancer Res; 2009 Sep; 29(9):3571-8. PubMed ID: 19667150
[TBL] [Abstract][Full Text] [Related]
35. Effects of vitamin D-binding protein on bone resorption stimulated by 1,25 dihydroxyvitamin D3.
Vargas S; Bouillon R; Van Baelen H; Raisz LG
Calcif Tissue Int; 1990 Sep; 47(3):164-8. PubMed ID: 2224592
[TBL] [Abstract][Full Text] [Related]
36. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
37. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ
Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745
[TBL] [Abstract][Full Text] [Related]
38. 1 alpha,25-Dihydroxyvitamin D3[1 alpha,25-(OH)2D3]-26,23-lactone inhibits 1,25-(OH)2D3-mediated fusion of mouse bone marrow mononuclear cells.
Ishizuka S; Kurihara N; Hakeda S; Maeda N; Ikeda K; Kumegawa M; Norman AW
Endocrinology; 1988 Aug; 123(2):781-6. PubMed ID: 3396507
[TBL] [Abstract][Full Text] [Related]
39. Studies on two new vitamin D analogs, EB 1089 and KH 1060: effects on bone resorption and osteoclast recruitment in vitro.
Wiberg K; Ljunghall S; Binderup L; Ljunggren O
Bone; 1995 Oct; 17(4):391-5. PubMed ID: 8573413
[TBL] [Abstract][Full Text] [Related]
40. Comparison of 22-oxacalcitriol and 1,25(OH)2D3 on bone metabolism in young X-linked hypophosphatemic male mice.
Halstead LR; Weinstein RS; Cheng SL; Rifas L; Avioli LV
Am J Physiol; 1996 Jan; 270(1 Pt 1):E141-7. PubMed ID: 8772486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
